C

Corbus Pharmaceuticals

44 employees

Corbus Pharmaceuticals is a clinical-stage pharmaceutical company focused on treating inflammatory and fibrotic diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Lupus
Biotechnology
Cystic Fibrosis
Dermatomyositis
Systemic Sclerosis
Inflammation
Rare Diseases
Pharmaceutical
Clinical Trials
systemic lupus erythematosus
Orphan diseases
Fibrosis
Scleroderma

Date founded

2014

Funding rounds raised

Total raised

$20M

from 4 investors over 4 rounds

C

Corbus Pharmaceuticals raised $15M on June 10, 2016

Investors: DAFNA Capital Management, LLC and Perceptive Advisors

C

Corbus Pharmaceuticals raised $20M on March 1, 2014

Investors: SternAegis Ventures

C

Corbus Pharmaceuticals raised undisclosed on January 1, 2010

Investors: Boston Harbor Angels Inc.

FAQ